Literature DB >> 25939554

Altered germinal center reaction and abnormal B cell peripheral maturation in PI3KR1-mutated patients presenting with HIGM-like phenotype.

Vassilios Lougaris1, Flavio Faletra2, Gaetana Lanzi3, Diego Vozzi2, Annalisa Marcuzzi2, Erica Valencic2, Elisa Piscianz2, AnnaMonica Bianco2, Martina Girardelli2, Manuela Baronio4, Claudia Loganes2, Anders Fasth5, Filippo Salvini6, Antonino Trizzino7, Daniele Moratto3, Fabio Facchetti8, Silvia Giliani3, Alessandro Plebani4, Alberto Tommasini2.   

Abstract

Entities:  

Keywords:  B cells; Germinal Center (GC) reaction; Hyper-IgM syndrome; PIK3R1

Mesh:

Substances:

Year:  2015        PMID: 25939554     DOI: 10.1016/j.clim.2015.04.014

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


× No keyword cloud information.
  18 in total

Review 1.  Immune Dysregulation and Disease Pathogenesis due to Activating Mutations in PIK3CD-the Goldilocks' Effect.

Authors:  Stuart G Tangye; Julia Bier; Anthony Lau; Tina Nguyen; Gulbu Uzel; Elissa K Deenick
Journal:  J Clin Immunol       Date:  2019-03-25       Impact factor: 8.317

2.  Autosomal Recessive Agammaglobulinemia Due to a Homozygous Mutation in PIK3R1.

Authors:  Paoyun Tang; Julia E M Upton; Michelle A Barton-Forbes; Marina I Salvadori; Meghan P Clynick; April K Price; Sharan L Goobie
Journal:  J Clin Immunol       Date:  2017-11-25       Impact factor: 8.317

3.  Patients with common variable immunodeficiency with autoimmune cytopenias exhibit hyperplastic yet inefficient germinal center responses.

Authors:  Neil Romberg; Carole Le Coz; Salomé Glauzy; Jean-Nicolas Schickel; Melissa Trofa; Brian E Nolan; Michele Paessler; Mina L Xu; Michele P Lambert; Saquib A Lakhani; Mustafa K Khokha; Soma Jyonouchi; Jennifer Heimall; Patricia Takach; Paul J Maglione; Jason Catanzaro; F Ida Hsu; Kathleen E Sullivan; Charlotte Cunningham-Rundles; Eric Meffre
Journal:  J Allergy Clin Immunol       Date:  2018-06-20       Impact factor: 10.793

4.  Dominant Splice Site Mutations in PIK3R1 Cause Hyper IgM Syndrome, Lymphadenopathy and Short Stature.

Authors:  Slavé Petrovski; Roberta E Parrott; Joseph L Roberts; Hongxiang Huang; Jialong Yang; Balachandra Gorentla; Talal Mousallem; Endi Wang; Martin Armstrong; Duncan McHale; Nancie J MacIver; David B Goldstein; Xiao-Ping Zhong; Rebecca H Buckley
Journal:  J Clin Immunol       Date:  2016-04-13       Impact factor: 8.317

Review 5.  PI3Kδ and primary immunodeficiencies.

Authors:  Carrie L Lucas; Anita Chandra; Sergey Nejentsev; Alison M Condliffe; Klaus Okkenhaug
Journal:  Nat Rev Immunol       Date:  2016-09-12       Impact factor: 53.106

Review 6.  Activated PI3Kinase Delta Syndrome-A Multifaceted Disease.

Authors:  Romane Thouenon; Nidia Moreno-Corona; Lucie Poggi; Anne Durandy; Sven Kracker
Journal:  Front Pediatr       Date:  2021-06-25       Impact factor: 3.418

7.  Two Monogenetic Disorders, Activated PI3-Kinase-δ Syndrome 2 and Smith-Magenis Syndrome, in One Patient: Case Report and a Literature Review of Neurodevelopmental Impact in Primary Immunodeficiencies Associated With Disturbed PI3K Signaling.

Authors:  Nidia Moreno-Corona; Loïc Chentout; Lucie Poggi; Romane Thouenon; Cecile Masson; Melanie Parisot; Lou Le Mouel; Capucine Picard; Isabelle André; Marina Cavazzana; Laurence Perrin; Anne Durandy; Saba Azarnoush; Sven Kracker
Journal:  Front Pediatr       Date:  2021-06-24       Impact factor: 3.418

Review 8.  Emerging roles of class I PI3K inhibitors in modulating tumor microenvironment and immunity.

Authors:  Pu Sun; Ling-Hua Meng
Journal:  Acta Pharmacol Sin       Date:  2020-09-16       Impact factor: 7.169

Review 9.  Epstein-Barr Virus Susceptibility in Activated PI3Kδ Syndrome (APDS) Immunodeficiency.

Authors:  Jean-Marie Carpier; Carrie L Lucas
Journal:  Front Immunol       Date:  2018-01-16       Impact factor: 7.561

Review 10.  Respiratory Manifestations of the Activated Phosphoinositide 3-Kinase Delta Syndrome.

Authors:  Alison M Condliffe; Anita Chandra
Journal:  Front Immunol       Date:  2018-03-05       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.